SVA
HEALTHCARESinovac Biotech Ltd
—PRE
Live · NASDAQ · May 8, Close
AI Insight
What's Moving SVA Today?
No stock-specific AI insight has been generated for SVA yet. Check back soon — insights are generated from recent news analysis.
Fundamentals
Market Cap$642M
P/E Ratio6.7
EPS$0.97
Dividend Yield8.50%
Dividend / Share—
ROE0.3%
Profit Margin0.2%
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding99.3M
SVA News
21 articles- [6-K] SINOVAC BIOTECH LTD Current Report (Foreign Issuer) | SVA SEC Filing - Form 6-KStock Titan·May 9, 2026
- SINOVAC Files Annual Report on Form 20-F for the Fiscal Year 2024Yahoo Finance·Apr 30, 2026
- OrbiMed Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC FilingMotley Fool·Feb 20, 2026
- Coxsackievirus Infections Market Research Report 2025-2035: High Burden of Pediatric and Neonatal Infections, Link to Type 1 Diabetes Risk, Advances in Vaccine Development Driving ExpansionYahoo Finance·Feb 6, 2026
- SINOVAC Announces Nasdaq Hearings Panel Grants Continued ListingYahoo Finance·Jan 22, 2026
- SINOVAC Provides Update on Antigua High Court Order and Auditor EngagementYahoo Finance·Jan 4, 2026
- Sinovac Receives Nasdaq Notification Regarding Late Filing of 2025 Half-Year ReportYahoo Finance·Jan 4, 2026
- Sinovac: Antigua Court Makes Interim Order Giving Board Control of the Company until the Trial of the Disputed 2025 Shareholder MeetingYahoo Finance·Dec 17, 2025
- SINOVAC Announces Receipt of Nasdaq Notice of Delisting and Intention to AppealYahoo Finance·Nov 18, 2025
- /C O R R E C T I O N -- Heng Ren Partners/Yahoo Finance·Nov 11, 2025
- Independent Sinovac Shareholders Express Strong Support for Immediate Dividend PaymentYahoo Finance·Nov 11, 2025
- SINOVAC Announces Appointment of Independent AuditorYahoo Finance·Oct 24, 2025
- SINOVAC Board Sets the Record Straight on July 8 Special Meeting of ShareholdersYahoo Finance·Jul 11, 2025
- Newly Elected Directors of Sinovac Hold the First Board MeetingYahoo Finance·Jul 10, 2025
- SINOVAC Board of Directors Strongly Denounces Deceptive and Illegal Claims by SAIF and the Imposter Former BoardYahoo Finance·Jul 9, 2025
- SINOVAC Board of Directors Provides Update on Status of US$55.00 Special Cash Dividend PaymentYahoo Finance·Jul 9, 2025
- SINOVAC Board of Directors Announces Adjournment of Special Meeting of Shareholders Until Appropriate Court Can Make a Final Decision on the Validity of the PIPE SharesYahoo Finance·Jul 9, 2025
- Sinovac Shareholders Vote to Remove Current Directors and Elect SAIF Partners Nominees to Board at Special MeetingYahoo Finance·Jul 9, 2025
- Appeal Decision By Eastern Caribbean Supreme Court Supports Right of Prime Success and Vivo Capital to Participate in Critical Sinovac Biotech Shareholder VoteYahoo Finance·Jul 9, 2025
- Final Reminder for SINOVAC Shareholders to Vote the WHITE Proxy Card "AGAINST" Misguided Proposals 1 and 2Yahoo Finance·Jul 7, 2025
- Federal Court in Massachusetts Denies Vivo Capital’s Petition for Relief on SINOVACYahoo Finance·Jul 7, 2025
All 21 articles loaded
Price Data
Open—
Previous Close—
Day High—
Day Low—
52 Week High$6.47
52 Week Low$6.47
Fundamentals
Market Cap$642M
P/E Ratio6.7
EPS$0.97
Dividend Yield8.50%
Dividend / Share—
ROE0.3%
Profit Margin0.2%
Debt / Equity—
Trading
Volume—
Avg Volume (10D)—
Shares Outstanding99.3M
About Sinovac Biotech Ltd
Sinovac Biotech Ltd., a biopharmaceutical company, focuses on the research, development, manufacture and marketing of vaccines against human infectious diseases in the People's Republic of China. The company is headquartered in Beijing, the People's Republic of China.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—